|
Macroglobulinemia, Waldenström's
|
|
Macroglobulinemia
|
Macroglobulinemia, Waldenström's Clinical Trials
- A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00398710 - Recruiting
Waldenström's Macroglobulinemia
- Patients with Advanced and/or Symptomatic Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00107614 - Active, not recruiting
Waldenstrom Macroglobulinemia
- Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00045695 - Active, not recruiting
Waldenstrom's Macroglobulinemia
- Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00250926 - Active, not recruiting
Waldenstrom's Macroglobulinemia
- Study of Epratuzumab (hLL2) in Patients with Waldenstrom''s Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00113802 - Active, not recruiting
Waldenstrom Macroglobulinemia
- Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00060346 - Active, not recruiting
Waldenstrom's Macroglobulinemia
- Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00041379 - Active, not recruiting
Waldenstrom's Macroglobulinemia
- Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00004889 - Active, not recruiting
Waldenstrom's Macroglobulinemia
- CC-5013 and Rituximab in Waldenstrom''s Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00142168 - Active, not recruiting
Waldenstrom''s Macroglobulinemia
- Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00422656 - Active, not recruiting
Waldenstrom's Macroglobulinemia
- Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00003512 - Active, not recruiting
refractory plasma cell neoplasm; Waldenstrom's Macroglobulinemia
- Combination Bortezomib and Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00422799 - Recruiting
Waldenstrom's Macroglobulinemia
- Thalidomide and Rituximab in Waldenstrom''s Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00142116 - Active, not recruiting
Waldenstrom''s Macroglobulinemia; Lymphoplasmacytic lymphoma
- Phase II Study of Campath-1H Antibody to Treat Waldenstrom''s Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00142181 - Active, not recruiting
Lymphoplasmacytic lymphoma; Waldenstrom''s Macroglobulinemia
- Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00566332 - Recruiting
Waldenström Macroglobulinemia; Lymphoplasmacytic Lymphoma; Splenic Marginal Zone Lymphoma
- Bortezomib and Rituxan for Patients With Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00492050 - Recruiting
Waldenstrom's Macroglobulinemia
- Anti-Angiogenesis Therapy Using Thalidomide in Patients with Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00083707 - Completed
Waldenstrom Macroglobulinemia
- Simvastatin in Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00575965 - Recruiting
Waldenstrom's Macroglobulinemia
- Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00003963 - Active, not recruiting
Waldenstrom's Macroglobulinemia; adult non-Hodgkin's lymphoma
- Low-Intensity Preparation and Allogeneic Transplant in Patients with Cancers of the Blood
ClinicalTrials.gov Identifier: NCT00146055 - Active, not recruiting
Myeloma, Plasma-Cell; Lymphoma, Malignant; Myeloproliferative Disorders; Myelodysplastic Syndromes; Waldenstrom''s Macroglobulinemia
- Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002779 - Active, not recruiting
Lymphoma; Lymphoma, Small Lymphocytic; Lymphoma, Mantle-Cell; Waldenstrom's Macroglobulinemia; Lymphoma, Mucosa-Associated Lymphoid Tissue
- Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00062244 - Completed
Waldenstrom's Macroglobulinemia
- High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon alfa in Treating Patients With Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00003416 - Completed
Waldenstrom's Macroglobulinemia
- Safety Study of the Proteasome Inhibitor PR-171 in Patients with Hematological Malignancies
ClinicalTrials.gov Identifier: NCT00150462 - Recruiting
Multiple Myeloma; Non-Hodgkin''s Lymphoma; Hodgkin''s Disease; Waldenstrom''s Macroglobulinemia
- Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00005609 - Completed
Waldenstrom's Macroglobulinemia
- Rituximab With or Without Interleukin-12 in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00026182 - Active, not recruiting
Waldenstrom's Macroglobulinemia; recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; ...
- Bone Marrow Transplantation in Treating Patients With Lymphoma
ClinicalTrials.gov Identifier: NCT00002829 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; Waldenstrom's Macroglobulinemia; recurrent grade I follicular small cleaved cell lymphoma; ...
- Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
ClinicalTrials.gov Identifier: NCT00058240 - Active, not recruiting
B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; Waldenstrom's Macroglobulinemia; recurrent small lymphocytic lymphoma
- Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00081068 - Completed
Waldenstrom's Macroglobulinemia
- Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00020800 - Completed
Waldenstrom's Macroglobulinemia
- Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00281983 - Active, not recruiting
Leukemia; Lymphoma
- Correlation of FC Gamma RIIA Receptor Response in Patients with Waldenstrom''s Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00142155 - Terminated
Waldenstrom''s Macroglobulinemia
- Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002510 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; Waldenstrom's Macroglobulinemia; recurrent grade III follicular large cell lymphoma; ...
- Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002745 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; Waldenstrom's Macroglobulinemia; recurrent grade I follicular small cleaved cell lymphoma; ...
- UCN-01 and Fludarabine to Treat Lymphoma and Leukemia
ClinicalTrials.gov Identifier: NCT00001822 - Recruiting
Chronic Lymphocytic Leukemia; Hairy Cell Leukemia; Leukemia; Lymphoma; Waldenstrom Macroglobulinemia
- Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00060294 - Completed
Waldenstrom's Macroglobulinemia
- Comparison of Fludarabine Plus Total-body Irradiation With Combination Chemotherapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00041288 - Active, not recruiting
Waldenstrom's Macroglobulinemia; refractory chronic lymphocytic leukemia; recurrent grade I follicular small cleaved cell lymphoma; ...
- Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002880 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; Waldenstrom's Macroglobulinemia; ...
- Bortezomib (Velcade) in Waldenstrom''s Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00142129 - Completed
Waldenstrom''s Macroglobulinemia; Lymphoplasmacytic lymphoma
- Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00004107 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
ClinicalTrials.gov Identifier: NCT00273936 - Recruiting
Acute Leukemia; Chronic Leukemia; Multiple Myeloma; Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma; Waldenstrom's Macroglobulinemia
- Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00031668 - Active, not recruiting
recurrent adult diffuse small noncleaved cell/Burkitt's lymphoma; recurrent adult T-cell leukemia/lymphoma; ...
- Sildenafil Citrate in Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00165295 - Terminated
Waldenstrom's Macroglobulinemia
- Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00004192 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Interferon alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non- Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003924 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer
ClinicalTrials.gov Identifier: NCT00004086 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00006473 - Completed
Waldenstrom's Macroglobulinemia; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; angioimmunoblastic T-cell lymphoma
- FR901228 in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00024180 - Completed
Waldenstrom's Macroglobulinemia; recurrent adult acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia; ...
- Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003605 - Active, not recruiting
stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...
- Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003663 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; stage III grade II follicular mixed cell lymphoma; ...
- Monoclonal Antibody Therapy in Treating Patients With Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00029367 - Completed
Leukemia; Lymphoma
- Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00005579 - Completed
adult non-Hodgkin's lymphoma
- 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma
ClinicalTrials.gov Identifier: NCT00005950 - Completed
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult T-cell leukemia/lymphoma; angioimmunoblastic T-cell lymphoma; ...
- Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00003143 - Completed
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003784 - Completed
stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
